High-throughput assay for evaluating dipeptidyl peptidase l activity

Details for Australian Patent Application No. 2009308458 (hide)

Owner Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Inventors Olson, Matthew; Todd, Matthew

Agent Shelston IP

Pub. Number AU-A-2009308458

PCT Pub. Number WO2010/048306

Priority 61/107,046 21.10.08 US

Filing date 21 October 2009

Wipo publication date 29 April 2010

International Classifications

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/048306 Priority application(s): WO2010/048306

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009308462-Animal model for evaluating vasomotor response in vivo

2009308454-Naphthamides as anticancer agents